David Whang

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary…

The American Journal of Cardiology · 1999 · 112 citations

Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management

Catheterization and Cardiovascular Interventions · 2001 · 90 citations